F. Daniel

500 total citations
13 papers, 374 citations indexed

About

F. Daniel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, F. Daniel has authored 13 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in F. Daniel's work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers) and Peptidase Inhibition and Analysis (2 papers). F. Daniel is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers) and Peptidase Inhibition and Analysis (2 papers). F. Daniel collaborates with scholars based in United Kingdom, United States and Belgium. F. Daniel's co-authors include J. Oates, David Cunningham, Mark Hill, Sheela Rao, A. Norman, David B. Smith, John P. Neoptolemos, Paul J. Ross, Robert E. Hawkins and James D. Evans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

F. Daniel

13 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Daniel United Kingdom 8 232 174 144 93 71 13 374
Jan Kuhlmann Germany 11 182 0.8× 132 0.8× 154 1.1× 46 0.5× 126 1.8× 21 444
Teresa Staiano Italy 11 118 0.5× 72 0.4× 82 0.6× 66 0.7× 77 1.1× 19 289
Keita Uchino Japan 12 215 0.9× 151 0.9× 59 0.4× 39 0.4× 86 1.2× 40 357
Kim L. Wang United States 8 122 0.5× 216 1.2× 175 1.2× 38 0.4× 130 1.8× 13 396
Ji Hyun Park South Korea 8 123 0.5× 146 0.8× 60 0.4× 36 0.4× 62 0.9× 22 307
Raffaella Longarini Italy 9 297 1.3× 123 0.7× 142 1.0× 113 1.2× 64 0.9× 16 409
Chun-yu Huang China 10 179 0.8× 164 0.9× 121 0.8× 72 0.8× 143 2.0× 13 429
Hirofumi Satake Japan 7 330 1.4× 300 1.7× 100 0.7× 65 0.7× 130 1.8× 17 529
Karin Rita Tamas Switzerland 5 493 2.1× 162 0.9× 97 0.7× 210 2.3× 64 0.9× 5 554
Norimichi Kan Japan 11 136 0.6× 143 0.8× 113 0.8× 42 0.5× 35 0.5× 36 347

Countries citing papers authored by F. Daniel

Since Specialization
Citations

This map shows the geographic impact of F. Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Daniel more than expected).

Fields of papers citing papers by F. Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Daniel. The network helps show where F. Daniel may publish in the future.

Co-authorship network of co-authors of F. Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of F. Daniel. A scholar is included among the top collaborators of F. Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Daniel. F. Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nozawa, Kaori, Rachel Parkes, F. Daniel, et al.. (2024). Large-scale CRISPR/Cas9 deletions within the WFDC gene cluster uncover gene functionality and critical roles in mammalian reproduction. Proceedings of the National Academy of Sciences. 121(51). e2413195121–e2413195121. 4 indexed citations
2.
Nozawa, Kaori, et al.. (2023). CUB domains are not required for OVCH2 function in sperm maturation in the mouse epididymis. Andrology. 12(3). 682–697. 3 indexed citations
3.
Lupini, Laura, Cristian Bassi, Luca Martella, et al.. (2017). Estrogen receptor mutation: a new strategy to overcome endocrine resistance. Annals of Oncology. 28. vi32–vi33. 1 indexed citations
4.
Corrie, Pippa, Charles B. Wilson, Simon Bond, et al.. (2012). A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications. British Journal of Cancer. 107(4). 585–587. 27 indexed citations
5.
Cunningham, David, Sujaya Rao, Naureen Starling, et al.. (2006). Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: The REAL 2 trial. Journal of Clinical Oncology. 24(18_suppl). LBA4017–LBA4017. 77 indexed citations
6.
Rao, Sheela, David Cunningham, Robert E. Hawkins, et al.. (2005). Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. British Journal of Cancer. 92(9). 1650–1654. 107 indexed citations
7.
Rao, Sheela, David Cunningham, Robert C. Hawkins, et al.. (2003). 44 Phase III trial comparing epirubicin, cisplatin and 5-FU (ECF) versus 5FU, etoposide and leucovorin (FELV) in previously untreated patients with advanced biliary cancer. European Journal of Cancer Supplements. 1(5). S17–S17. 2 indexed citations
8.
9.
Evans, James D., F. Daniel, J Carmichael, et al.. (2001). A phase II trial of marimastat in advanced pancreatic cancer. British Journal of Cancer. 85(12). 1865–1870. 73 indexed citations
10.
Primrose, John, Harry Bleiberg, F. Daniel, et al.. (1999). Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen. British Journal of Cancer. 79(3-4). 509–514. 52 indexed citations
11.
Collinson, Michelle, F. Daniel, C. Tyrrell, & C. Teasdale. (1993). Response of Carcinoma of the Prostate to Withdrawal of Flutamide. British Journal of Urology. 72(5). 662–663. 10 indexed citations
12.
Daniel, F., et al.. (1991). A pilot study of stanozolol for advanced breast carcinoma. Cancer. 67(12). 2966–2968. 7 indexed citations
13.
Daniel, F., Paul Macleod, & C. Tyrrell. (1990). Megestrol Acetate in Relapsed Carcinoma of Prostate. British Journal of Urology. 65(3). 275–277. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Kuhlmann Breakdown of academic impact, for papers by Teresa Staiano Breakdown of academic impact, for papers by Keita Uchino Breakdown of academic impact, for papers by Kim L. Wang Breakdown of academic impact, for papers by Ji Hyun Park Breakdown of academic impact, for papers by Raffaella Longarini Breakdown of academic impact, for papers by Chun-yu Huang Breakdown of academic impact, for papers by Hirofumi Satake Breakdown of academic impact, for papers by Karin Rita Tamas Breakdown of academic impact, for papers by Norimichi Kan
Rankless by CCL
2026